The deal is 2019’s second-biggest medtech flotation, and the fourth-biggest ever.
Investors swerve traditional medical devices in favour of artificial intelligence-enabled diagnostics.
Voxeleron is, like Google’s related company Deepmind, using artificial intelligence to analyse ocular images. Unlike Deepmind, it is employing a targeted approach.
The industry has its work cut out to rebuild trust in the tech following doubts about one pioneer, IBM Watson.
Since becoming a pure-play health tech group Philips has been buying like crazy. Might Siemens Healthineers and GE Healthcare join in?
Drug discovery is getting harder, and some companies are turning to machine learning to look for new targets.
Big pharma is using machine learning to improve the drug development process – but can the tech live up to the hype?
Sequencing data is all well and good, but what does it mean?
Boehringer gets diggi with it.